Introduction
Probands and methods
Group A | Group B | Group C | Group D | |||
---|---|---|---|---|---|---|
Phakic | Pseudophakic | Total | ||||
Number of test persons | 28 | 44 | 34 | 32 | 24 | 56 |
Mean age (years) ± standard deviation | 17.5 ± 2.0 | 26.3 ± 4.5 | 50.9 ± 5.5 | 69.7 ± 7.0 | 74.3 ± 7.8 | 71.7 ± 7.6 |
Number of males Percentage (%) | 12 42.9 | 18 40.9 | 15 44.1 | 15 46.9 | 9 37.5 | 24 42.9 |
Number of females Percentage (%) | 16 57.1 | 26 59.1 | 19 55.9 | 17 53.1 | 15 62.5 | 32 57.1 |
Group A00 | Group A10 | Group B00 | Group B10 | Group C00 | Group C10 | Group D00 | Group D10 | Group D01 | Group D11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mean age | 17.8 | 17.3 | 26.4 | 26.3 | 50.5 | 51.1 | 71.9 | 67.7 | 75.4 | 73.6 |
SD | 1.2 | 2.5 | 4.1 | 4.9 | 6.2 | 5.0 | 6.3 | 7.1 | 6.8 | 8.5 |
VEP measurements
Statistical analysis
Results
Fullfield pattern-reversal VEP (FF-PR-VEP)
N75 [ms] | P100 [ms] | N135 [ms] | N75-P100 [μV] | |
---|---|---|---|---|
Total (n = 138) | 69,55 ± 10,24 (47,20 – 96,50) | 102,58 ± 7,26 (85,30 – 125,00) | 145,31 ± 15,82 (109,00 – 190,00) | 15,66 ± 6,42 (4,40 – 45,30) |
Group A (n = 28) | 67,44 ± 7,00 (50,70 – 80,10) | 102,13 ± 8,29 (91,20 – 125,00) | 147,68 ± 19,95 (118,00 – 190,00) | 18,49 ± 8,26 (6,33 – 45,30) |
Group B (n = 44) | 69,83 ± 9,43 (51,30 – 88,90) | 100,01 ± 6,41 (85,30 – 114,00) | 147,05 ± 16,78 (114,00 – 189,00) | 15,45 ± 6,25 (6,38 – 35,00) |
Group C (n = 34) | 69,50 ± 9,52 (54,20 – 91,80) | 103,98 ± 6,32 (91,20 – 120,00) | 141,97 ± 12,45 (125,00 – 179,00) | 15,89 ± 5,46 (7,96 – 31,30) |
Group D (n = 32) | 71,07 ± 13,93 (47,20 – 96,50) | 105,02 ± 7,48 (91,80 – 119,00) | 144,41 ± 13,47 (109,00 – 181,00) | 13,22 ± 4,86 (4,40 – 23,80) |
Target variable | ANOVA (p-value) | Significance of coefficient | Regression coefficient B | ||
---|---|---|---|---|---|
Age | Sex | Age | Sex | ||
N75 [ms] | 0,520 | 0,338 | 0,487 | 0,037 | − 1,230 |
P100 [ms] | 0,003* | 0,016* | 0,020* | 0,071* | − 2,844* |
N135 [ms] | 0,110 | 0,163 | 0,096 | − 0,091 | − 4,521 |
Ln(N75-P100) [μV] | < 0,001* | 0,011* | < 0,001* | − 0,004* (0,996) | 0,292* (1,339) |
N75 [ms] | P100 [ms] | N135 [ms] | N75-P100 [μV] | |
---|---|---|---|---|
Total (n = 138) | 78,09 ± 7,30 (55,40–98,30) | 103,81 ± 7,77 (84,20–124,00) | 144,95 ± 12,78 (112,00–185,00) | 16,30 ± 7,53 (5,07–44,30) |
Group A (n = 28) | 74,93 ± 6,35 (62,40–84,80) | 101,50 ± 8,43 (84,20–122,00) | 138,21 ± 11,21 (112,00–156,00) | 17,19 ± 8,82 (6,14–44,30) |
Group B (n = 44) | 75,99 ± 7,33 (55,40–87,10) | 101,54 ± 6,21 (91,80–120,00) | 145,14 ± 12,13 (122,00–185,00) | 15,57 ± 8,30 (5,07–41,40) |
Group C (n = 34) | 79,19 ± 5,73 (64,80–88,90) | 103,96 ± 7,78 (90,00–124,00) | 144,97 ± 14,39 (123,00–181,00) | 17,12 ± 5,77 (7,08–31,50) |
Group D (n = 32) | 82,58 ± 7,30 (67,70–98,30) | 108,78 ± 7,05 (93,00–121,00) | 150,56 ± 10,69 (135,00–176,00) | 15,65 ± 7,00 (5,65–31,40) |
Target variable | ANOVA (p-value) | Significance of coefficient | Regression coefficient B | ||
---|---|---|---|---|---|
Age | Sex | Age | Sex | ||
N75 [ms] FF 20.4′ | < 0,001* | < 0,001* | 0,911 | 0,144* | − 0,129 |
P100 [ms] FF 20.4′ | < 0,001* | < 0,001* | 0,965 | 0,142* | − 0,055 |
Ln(N135) [ms] FF 20.4′ | 0,001* | < 0,001* | 0,337 | 0,001* (1,001) | 0,014 (1,014) |
Ln(N75-P100) [μV] FF 20.4′ | < 0,001* | 0,749 | < 0,001* | 0,001 (1,001) | 0,430* (1,537) |
Target variable | N75 [ms] | P100 [ms] | N135 [ms] | N75-P100 [μV] |
---|---|---|---|---|
Phakic (n = 32) | 71,07 ± 13,93 (47,20–96,50) | 105, 02 ± 7,48 (91,80–119,00) | 144,41 ± 13,47 (109,00–181,00) | 13,22 ± 4,86 (4,40–23,80) |
Pseudophakic (n = 24) | 68,38 ± 13,45 (51,30–96,50) | 105,37 ± 9,33 (83,60–119,00) | 149,25 ± 18,36 (121,00–203,00) | 13,98 ± 5,16 (6,89–23,50) |
Target variable | N75 [ms] | P100 [ms] | N135 [ms] | N75-P100 [μV] |
---|---|---|---|---|
Phakic (n = 32) | 82,58 ± 7,30 (67,70–98,30) | 108,78 ± 7,05 (93,00–121,00) | 150,56 ± 10,69 (135,00–176,00) | 15,65 ± 7,00 (5,65–31,40) |
Pseudophakic (n = 24) | 83,86 ± 7,20 (68,90–99,40) | 110,89 ± 8,33 (98,80–128,00) | 154,96 ± 21,41 (126,00–227,00) | 17,69 ± 7,18 (7,56–36,20) |
Double-peaked VEP
N75 [ms] | P100 [ms] 1. peak | P100 [ms] 2.peak | |
---|---|---|---|
Total (n = 11) | 68.89 ± 16.95 (47.20–94.10) | 77.85 ± 5.66 (70.40–88.60) | 105.73 ± 8.87 (91.8–118.00) |
Extrafoveal pattern onset–offset VEP (EF-P-ON/OFF-VEP)
C1 [ms] | C2 [ms] | C3 [ms] | C1–C2 [μV] | |
---|---|---|---|---|
Total (n = 138) | 77,18 ± 8,34 (56,00–115,00) | 102,95 ± 11,84 (73,60–131,00) | 134,72 ± 21,99 (89,40–217,00) | 13,48 ± 9,29 (0,02–63,60) |
Group A (n = 28) | 74,91 ± 10,68 (61,30–115,00) | 94,79 ± 12,00 (73,60–126,00) | 121,35 ± 20,24 (89,40–171,00) | 7,58 ± 6,86 (0,02–25,60) |
Group B (n = 44) | 73,65 ± 7,14 (56,00–90,60) | 98,02 ± 8,45 (74,80–121,00) | 126,00 ± 20,11 (101,00–176,00) | 9,13 ± 5,42 (0,95–22,70) |
Group C (n = 34) | 78,68 ± 6,61 (63,00–94,10) | 106,48 ± 8,42 (88,90–122,00) | 140,88 ± 12,61 (111,00–174,00) | 19,07 ± 10,69 (5,40–63,60) |
Group D (n = 32) | 82,43 ± 6,12 (71,80–94,10) | 113,10 ± 10,21 (93,00–131,00) | 151,84 ± 20,87 (107,00–217,00) | 18,70 ± 7,54 (7,15–38,00) |
C1 [ms] | C2 [ms] | C3 [ms] | C1–C2 [μV] | |
---|---|---|---|---|
Total (n = 138) | 77,76 ± 6,71 (59,50 – 94,10) | 102,79 ± 12,41 (71,80 – 131,00) | 131,67 ± 23,96 (88,90 – 213,00) | 12,43 ± 9,15 (0,01 – 63,20) |
Group A (n = 28) | 76,06 ± 6,52 (64,80 – 90,60) | 93,73 ± 10,83 (71,80 – 120,00) | 114,61 ± 18,23 (88,90 – 169,00) | 6,45 ± 5,58 (0,01 – 21,70) |
Group B (n = 44) | 76,32 ± 5,66 (66,00 – 88,90) | 97,07 ± 7,43 (81,80 – 113,00) | 120,30 ± 18,48 (98,30 – 181,00) | 8,04 ± 5,06 (0,34 – 19,00) |
Group C (n = 34) | 78,27 ± 6,85 (59,50 – 93,00) | 107,51 ± 11,45 (75,90 – 131,00) | 140,03 ± 17,38 (106,00 – 179,00) | 17,13 ± 10,98 (2,61 – 63,20) |
Group D (n = 32) | 80,68 ± 7,27 (61,30 – 94,10) | 113,58 ± 9,87 (93,00 – 129,00) | 153,34 ± 21,06 (107,00 – 213,00) | 18,69 ± 7,41 (7,93 – 37,50) |
Target value | ANOVA (p-value) | Significance of coefficient | Regression coefficient B | ||
---|---|---|---|---|---|
Age | Sex | Age | Sex | ||
C1 [ms] | < 0,001* | < 0,001* | 0,612 | 0,162* | 0,672 |
C2 [ms] | < 0,001* | < 0,001* | 0,820 | 0,349* | − 0,370 |
C3 [ms] | < 0,001* | < 0,001* | 0,837 | 0,609* | − 0,644 |
C1-C2 [μV] | < 0,001* | < 0,001* | < 0,001* | 0,255* | 4,892* |
Target value | ANOVA (p-value) | Significance of coefficient | Regression coefficient B | ||
---|---|---|---|---|---|
Age | Sex | Age | Sex | ||
C1 [ms] | 0,006* | 0,002* | 0,520 | 0,085* | − 0,723 |
C2 [ms] | < 0,001* | < 0,001* | 0,767 | 0,387* | − 0,489 |
C3 [ms] | < 0,001* | < 0,001* | 0,950 | 0,779* | 0,193 |
Ln(C1–C2) [μV] | < 0,001* | < 0,001* | < 0,001* | 0,030* (1,030) | 0,561* (1,752) |